Venture debt is financing for growth companies whose risk profile depends partly on future enterprise value and investor support, rather than established profitability alone. It can fund commercial expansion, product development or acquisitions alongside equity. The attraction is straightforward: shareholders may retain more ownership if the company reaches a stronger valuation before its next equity round. The obligation is equally important: borrowed capital must be repaid, and contractual restrictions can narrow management’s choices when performance disappoints. For European startups preparing their 2027 funding plans, the relevant question is how much debt the business can absorb while preserving strategic flexibility. This guide takes an October 2026 perspective. It examines the financing decision using information available by 26 October 2026, without assuming future interest rates, lender appetite or funding-market outcomes.

Venture debt sits between risk-bearing equity and lending supported by established cash generation or readily realisable assets. A young software business may have recurring customers but negative cash flow because it invests heavily in sales. An industrial technology company may have validated its product but need working capital before customer deliveries generate cash. Both can have a financing need that conventional profit-based credit analysis struggles to accommodate. The loan does not remove the underlying business risk. It reallocates part of that risk through repayment rights, security, covenants and sometimes equity participation. Venture lenders therefore examine the quality of revenue, the funding history and the route to a refinancing, exit or internally funded repayment. A recognised shareholder can help establish credibility, but its presence is not a contractual guarantee of future investment. Debt is most useful when it finances a defined improvement in the business: stronger recurring revenue, a completed customer rollout or a demonstrable reduction in technical risk. It becomes more difficult to justify when the purpose is simply to defer a necessary valuation reset. Founders should distinguish a bridge to an attainable milestone from a bridge to an assumed recovery in investor sentiment. The former can change financing capacity; the latter leaves the repayment problem unresolved.

European venture debt comprises bank balance-sheet lending, specialist private-credit strategies and public-sector financing. These channels have different mandates and underwriting processes, so market availability cannot be inferred from one headline transaction. A facility supporting a large capital-intensive scale-up also says little about the terms available to a smaller recurring-revenue business. Public institutions provide an additional route. In November 2025, the European Investment Bank announced €25 million of financing for Trailer Dynamics, illustrating the application of venture debt to industrial innovation. Germany’s KfW announced the expansion of Venture Tech Growth Financing in August 2022, including cooperation with private lenders. These examples establish the breadth of financing channels, rather than an entitlement to funding for companies in similar sectors. For a 2027 budget, management should translate this fragmented landscape into financing scenarios. The base case should not rely on an uncommitted facility or a forecast reduction in reference rates. A stronger planning approach separates capital already available from capital subject to approval, milestones or new equity. It also distinguishes a lender’s geographic marketing coverage from its ability to lend to the specific borrower entity. European headquarters alone do not establish eligibility across all programmes or lending platforms.

A venture debt term sheet combines several instruments of risk allocation. The commitment defines the maximum facility size, while availability conditions determine how much can actually be borrowed. A second tranche may depend on revenue, new equity or a product milestone. Until those tests are satisfied, that tranche should not be treated as unrestricted liquidity in the operating plan. An initial interest-only period may defer principal repayments. Amortisation then reduces the outstanding balance over time, while a bullet structure leaves more principal due at maturity. These profiles can produce very different cash outcomes even with an identical stated interest rate. Payment-in-kind interest preserves cash initially but increases the balance that must ultimately be serviced or refinanced. Warrants give the lender a contractual right to acquire equity on specified terms. Warrant coverage expressed as a percentage of a loan is not the same as a percentage ownership stake. The share price, exercise mechanics and fully diluted capitalisation determine the resulting dilution. Fees payable at drawdown, maturity or early repayment must also enter the financing model. Security and covenants govern behaviour as well as recovery. Restrictions may cover additional borrowing, acquisitions, disposals and transfers of intellectual property. DLA Piper’s July 2024 analysis highlights acquisition-consent provisions in venture loan agreements. For a company planning consolidation, permitted acquisition baskets and consent procedures can matter as much as the initial cheque.

The appropriate loan amount follows from the downside cash model, rather than a fixed percentage of the last equity round. Management should calculate the incremental liquidity provided after fees, cash interest, amortisation and minimum-cash requirements. A facility that appears to add several months of funding can deliver materially less usable time once its servicing obligations are included. Consider an illustrative €3 million loan drawn in full at a 10% annual cash interest rate, with no principal repayment during its first year. Interest alone consumes €300,000 over that year. A 2% upfront fee costs another €60,000. The company receives €2.94 million net of that fee, while retaining a €3 million principal obligation. This is a simplified scenario, not a market quotation, and excludes warrants, legal expenses and other charges. The comparison with equity must be state-dependent. Debt can preserve shareholder value if operating performance improves, but fixed payments can destroy flexibility if sales slip. A priced equity round provides a larger loss-absorbing cushion, while equipment leasing or receivables finance may isolate a more specific funding need. The board should compare alternatives using the same operating assumptions and funding horizon. A cheaper headline coupon is not evidence of a lower overall economic cost if the structure forces an earlier refinancing.

Bank lenders can combine a term loan with transaction banking, guarantees or working-capital products. That relationship may simplify administration, but borrowers should understand deposit requirements and any security over operating accounts. A specialist debt fund may evaluate a different risk profile or offer a bespoke repayment structure, although flexibility is negotiated and can carry a higher economic cost. BlackRock’s acquisition of Kreos, completed in August 2023, demonstrates the involvement of large asset managers in European venture and growth lending. The acquisition announcement identified technology and healthcare as core areas. It should be read as evidence of a platform’s history and focus, not a promise that any particular company or facility size will be accepted. Public lenders add policy and eligibility considerations to the commercial assessment. The EIB’s financing of industrial innovation and KfW’s private-lender cooperation model illustrate different routes into this segment. Borrowers should test fit before committing significant management time. The relevant questions concern permitted use of proceeds, geography, minimum scale, investor requirements and execution dependencies. A useful lender comparison focuses on the proposed transaction: net cash available, permitted operating actions, security scope, repayment burden and behaviour under stress. Published portfolio names are a starting point for diligence. References from borrowers that experienced missed budgets or restructuring can reveal more about a lender’s approach than successful fundraising announcements.

Preparation should begin while the company retains meaningful choice. A lender process requires consistent financial reporting, a defensible forecast, a reconciled capitalisation table and clarity on existing security. Management should explain what the proposed funding accomplishes and identify the evidence that will demonstrate progress. A narrative based only on addressable-market size does not answer how the lender will be repaid. The most useful stress case combines slower sales with a delayed equity round. Testing these separately understates their correlation: weaker execution often reduces both cash generation and investor appetite. The board should identify the first covenant pressure point, the minimum liquidity position and the operational changes available before either becomes critical. Refinancing should be treated as an execution project with its own lead time. Maturity can arrive before a business becomes financeable on conventional terms, even if revenue has grown. Early-repayment charges, warrant survival and security-release arrangements affect the transition to a new lender or an equity-funded repayment. For 2027 planning, the strategic objective is to preserve options through the period in which uncertainty is highest. A smaller facility with accessible drawdowns and manageable repayment can be more valuable than a larger commitment dependent on optimistic milestones. Debt capacity should follow evidence of resilience, rather than the ambition of the fundraising target.

Venture debt can improve a startup’s capital structure when the funding produces measurable progress before repayment pressure becomes material. Its value comes from the interaction between operating execution, timing and ownership, rather than the absence of an immediate equity issuance. A loan that preserves shares but weakens the company’s ability to survive a delay may be economically expensive. European founders preparing for 2027 should therefore begin with a combined operating and financing model. The decision should remain credible under slower growth, restricted drawdowns and a later equity round. Where those conditions cannot be met, additional equity or financing tied to specific assets may offer a stronger foundation.

Yes, loss-making companies can be candidates where the lender has confidence in their revenue quality, equity backing and repayment prospects. Profitability is not the sole test. A company still needs a credible funding plan and enough liquidity to meet the contractual obligations under a realistic downside scenario.

The loan principal does not itself issue shares, but the financing may include warrants or other equity-linked remuneration. Those rights can dilute existing shareholders. Even without warrants, fees, interest and repayment obligations impose an economic cost, so non-dilutive should not be treated as synonymous with inexpensive.

That depends on availability conditions, commitment fees, interest expense and liquidity risk. Drawing early secures cash but starts financing costs. Waiting can reduce those costs while leaving exposure to unmet conditions or an expiring availability period. The decision should be modelled against the actual agreement and operating forecast.